VILNIUS, Lithuania, Dec. 30, 2024 /PRNewswire/ — BingX, a leading global cryptocurrency exchange, proudly celebrates the one-year anniversary of Vivien Lin’s tenure as Chief Product Officer (CPO). Lin’s leadership has been instrumental in redefining BingX’s product strategy, focusing on…
Tag: PR Newswire
HANGZHOU, China, Dec. 30, 2024 /PRNewswire/ — Dahua Technology, a world-leading video-centric AIoT solution and service provider, has officially obtained the ISO 37301:2021 Compliance Management System Certification from British Standards Institution (BSI). This milestone makes Dahua the…
ISTANBUL, Dec. 30, 2024 /PRNewswire/ — Global smart-home brand DREAME’s sub-brand MOVA has announced the launch of new products in Turkey under the slogan “Move on, ventures await.” Targeting younger generations, MOVA is expanding its market presence across North America, Europe,…
İSTANBUL, 30 Aralık 2024 /PRNewswire/ — Küresel akıllı ev markası DREAME’nin alt markası MOVA, “Move on, ventures await” sloganıyla Türkiye’de yeni ürünlerini piyasaya sürdüğünü duyurdu. Genç nesilleri hedefleyen MOVA Kuzey Amerika, Avrupa, Avustralya, Güneydoğu Asya, Doğu Asya ve Orta…
Présentation de l’acide hyaluronique, des exosomes et du PDRN SÉOUL, Corée du Sud, 30 décembre 2024 /PRNewswire/ — Maypharm Co, Ltd, l’un des principaux innovateurs en matière de produits médicaux et dermo-cosmétiques, introduit avec fierté Hyalmass Aqua-Exosome sur le marché mondial. Il…
Neuartige Kombination aus Hyaluronsäure, Exosomen und PDRN SEOUL, Südkorea, 30. Dezember 2024 /PRNewswire/ — Maypharm Co., Ltd, ein führender Innovator im Bereich medizinischer und hautkosmetischer Produkte, kündigt mit Stolz die weltweite Markteinführung von Hyalmass Aqua-Exosome an,…
– Maypharm presenta Hyalmass Aqua-Exosome, un revolucionario relleno híbrido: el futuro de la hidratación y regeneración de la piel Introducción al ácido hialurónico, los exosomas y el PDRN SEÚL, Corea del Sur, 30 de diciembre de 2024 /PRNewswire/ — Maypharm Co., Ltd., un innovador líder…
Introducing Hyaluronic Acid, Exosomes, and PDRN SEOUL, South Korea, Dec. 30, 2024 /PRNewswire/ — Maypharm Co., Ltd., a leading innovator in medical and dermo-cosmetic products, proudly introduces the global launch of Hyalmass Aqua-Exosome, a groundbreaking hybrid mesotherapy filler…
Introducing Hyaluronic Acid, Exosomes, and PDRN SEOUL, South Korea, Dec. 30, 2024 /PRNewswire/ — Maypharm Co., Ltd., a leading innovator in medical and dermo-cosmetic products, proudly introduces the global launch of Hyalmass Aqua-Exosome, a groundbreaking hybrid mesotherapy filler…
SUZHOU, China, Dec. 30, 2024 /PRNewswire/ — Hangzhou Sino-US Huadong Medicine Co., Ltd. (hereinafter referred to as “Huadong Medicine”), a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963), and SynerK PharmaTech (Suzhou) Co., Ltd. (hereinafter referred to as “SynerK”)…
